Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBITDA (2018 - 2025)

Historic EBITDA for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to -$15.3 million.

  • Evolus' EBITDA rose 2068.23% to -$15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.0 million, marking a year-over-year decrease of 444.16%. This contributed to the annual value of -$50.9 million for FY2024, which is 1760.74% up from last year.
  • Evolus' EBITDA amounted to -$15.3 million in Q3 2025, which was up 2068.23% from -$16.9 million recorded in Q2 2025.
  • Evolus' 5-year EBITDA high stood at $6.4 million for Q1 2021, and its period low was -$23.5 million during Q2 2022.
  • Its 5-year average for EBITDA is -$15.0 million, with a median of -$16.9 million in 2025.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 13279.87% in 2021, then tumbled by 37501.95% in 2022.
  • Quarter analysis of 5 years shows Evolus' EBITDA stood at -$18.2 million in 2021, then rose by 27.75% to -$13.1 million in 2022, then rose by 11.28% to -$11.7 million in 2023, then surged by 39.86% to -$7.0 million in 2024, then crashed by 118.0% to -$15.3 million in 2025.
  • Its last three reported values are -$15.3 million in Q3 2025, -$16.9 million for Q2 2025, and -$18.8 million during Q1 2025.